Cargando…
Anticancer activity of repurposed hemostatic agent desmopressin on AVPR2-expressing human osteosarcoma
Osteosarcoma is the most prevalent primary bone malignancy. Due to its high aggressiveness, novel treatment strategies are urgently required to improve survival of patients with osteosarcoma, especially those with advanced disease. Desmopressin (dDAVP) is a widely used blood-saving agent that has be...
Autores principales: | Sobol, Natasha Tatiana, Solernó, Luisina María, Beltrán, Brady, Vásquez, Liliana, Ripoll, Giselle Vanina, Garona, Juan, Alonso, Daniel Fernando |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8027742/ https://www.ncbi.nlm.nih.gov/pubmed/33850538 http://dx.doi.org/10.3892/etm.2021.9998 |
Ejemplares similares
-
Propranolol blocks osteosarcoma cell cycle progression, inhibits angiogenesis and slows xenograft growth in combination with cisplatin-based chemotherapy
por: Solernó, Luisina M., et al.
Publicado: (2022) -
Vasopressin Analog [V(4)Q(5)]dDAVP Exerts Cooperative Anticancer Effects in Combination With Low-Dose 5-Fluorouracil on Aggressive Colorectal Cancer Models
por: Sobol, Natasha T., et al.
Publicado: (2023) -
Metastasis: Recent Discoveries and Novel Perioperative Treatment Strategies with Particular Interest in the Hemostatic Compound Desmopressin
por: Alonso, D.F, et al.
Publicado: (2011) -
Reduction of tumor angiogenesis induced by desmopressin in a breast cancer model
por: Ripoll, Giselle V., et al.
Publicado: (2013) -
Oral disintegrating desmopressin tablet is effective for partial congenital
nephrogenic diabetes insipidus with AVPR2 mutation: a case
report
por: Ikegawa, Kento, et al.
Publicado: (2022)